TP53 and colorectal cancer: Furthermore, using SW480 and HT-29 colorectal cancer cell lines overexpressing mutant p53, the SN-38 and CQ combination treatment did not duplicate the synergistic cytotoxic effect; instead the combination index suggested a slightly antagonistic effect.